SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-08-002781
Filing Date
2008-03-14
Accepted
2008-03-14 15:23:48
Documents
13
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2183521z10-k.htm 10-K 1323213
2 EXHIBIT 10.51 a2183521zex-10_51.htm EX-10.51 114705
3 EXHIBIT 10.52 a2183521zex-10_52.htm EX-10.52 10524
4 EXHIBIT 23.1 a2183521zex-23_1.htm EX-23.1 3067
5 EXHIBIT 31.1 a2183521zex-31_1.htm EX-31.1 7849
6 EXHIBIT 31.2 a2183521zex-31_2.htm EX-31.2 7394
7 EXHIBIT 32.1 a2183521zex-32_1.htm EX-32.1 4819
8 G186877.JPG g186877.jpg GRAPHIC 22105
9 G908813.JPG g908813.jpg GRAPHIC 69077
10 G382376.JPG g382376.jpg GRAPHIC 23862
11 G56491.JPG g56491.jpg GRAPHIC 24526
12 G353761.JPG g353761.jpg GRAPHIC 17540
13 G785324.JPG g785324.jpg GRAPHIC 7463
  Complete submission text file 0001047469-08-002781.txt   1700441
Mailing Address
Business Address 15 SKYLINE DRIVE HAWTHORNE NY 10532 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50513 | Film No.: 08689296
SIC: 2836 Biological Products, (No Diagnostic Substances)